These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 33035415)

  • 1. [Pompe disease treated with enzyme replacement therapy in pregnancy].
    Grosz Z; Várdi KV; Molnár JM
    Ideggyogy Sz; 2020 Sep; 73(9-10):339-344. PubMed ID: 33035415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy and immunotherapy lead to significant functional improvement in two children with Pompe disease: a case report.
    Castellar-Leones SM; Ortiz-Corredor F; Manrique-Hernández D; Sánchez-Peñarete D; Ruiz-Ospina E; Soto-Peña D; Correa-Arrieta C
    J Med Case Rep; 2024 Jul; 18(1):328. PubMed ID: 39020349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pompe Disease: New Developments in an Old Lysosomal Storage Disorder.
    Meena NK; Raben N
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32962155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Patients With Late-Onset Pompe Disease in France: Insights From the French Pompe Registry in 2022.
    Lefeuvre C; De Antonio M; Bouhour F; Tard C; Salort-Campana E; Lagrange E; Behin A; Sole G; Noury JB; Sacconi S; Magot A; Nadaj-Pakleza A; Lacour A; Beltran S; Spinazzi M; Cintas P; Renard D; Michaud M; Bedat-Millet AL; Prigent H; Taouagh N; Arrassi A; Hamroun D; Attarian S; Laforêt P;
    Neurology; 2023 Aug; 101(9):e966-e977. PubMed ID: 37419682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Comments on "Increasing Enzyme Mannose-6-Phosphate Levels but Not Miglustat Coadministration Enhances the Efficacy of Enzyme Replacement Therapy in Pompe Mice".
    George K; Anding A
    J Pharmacol Exp Ther; 2024 May; 389(3):313-314. PubMed ID: 38772716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry.
    Martinez-Marin RJ; Reyes-Leiva D; Nascimento A; Muelas N; Dominguez-González C; Paradas C; Olivé M; García-Romero M; Pascual-Pascual SI; Grau JM; Barba-Romero MA; Gomez-Caravaca MT; de Las Heras J; Casquero P; Mendoza MD; de León JC; Gutierrez A; Morís G; Blanco-Lago R; Ramos-Fransi A; Pintós G; García-Antelo MJ; Rabasa M; Morgado Y; Usón M; Miralles FJ; Bárcena-Llona JE; Gómez-Belda AB; Pedraza-Hueso MI; Hortelano M; Colomé A; Garcia-Martin G; Lopez de Munain A; Jericó I; Galán-Dávila L; Pardo J; Salgueiro-Origlia G; Alonso-Pérez J; Pla-Junca F; Schiava M; Segovia-Simón S; Díaz-Manera J
    Neuromuscul Disord; 2024 Jan; 34():1-8. PubMed ID: 38087756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02).
    Byrne BJ; Schoser B; Kishnani PS; Bratkovic D; Clemens PR; Goker-Alpan O; Ming X; Roberts M; Vorgerd M; Sivakumar K; van der Ploeg AT; Goldman M; Wright J; Holdbrook F; Jain V; Benjamin ER; Johnson F; Das SS; Wasfi Y; Mozaffar T
    J Neurol; 2024 Apr; 271(4):1787-1801. PubMed ID: 38057636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of Pompe disease on smooth muscle: a review.
    McCall AL; Salemi J; Bhanap P; Strickland LM; Elmallah MK
    J Smooth Muscle Res; 2018; 54(0):100-118. PubMed ID: 30787211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease.
    Tang S; Ma J; Meng H; Guo J; Cao S; Wang B
    Medicine (Baltimore); 2021 Jan; 100(3):e24276. PubMed ID: 33546050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and Management of Late-Onset Pompe Disease].
    Hahn P; Siefen RG; Benz K; Jackowski J; Köhler C; Lücke T
    Fortschr Neurol Psychiatr; 2024 Jan; 92(1-02):33-40. PubMed ID: 37494148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmias in patients receiving enzyme replacement therapy for infantile Pompe disease.
    McDowell R; Li JS; Benjamin DK; Morgan C; Becker A; Kishnani PS; Kanter RJ
    Genet Med; 2008 Oct; 10(10):758-62. PubMed ID: 18813140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pompe Disease: From Basic Science to Therapy.
    Kohler L; Puertollano R; Raben N
    Neurotherapeutics; 2018 Oct; 15(4):928-942. PubMed ID: 30117059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024.
    Schoser B; van der Beek NAME; Broomfield A; Brusse E; Diaz-Manera J; Hahn A; Hundsberger T; Kornblum C; Kruijshaar M; Laforet P; Mengel E; Mongini T; Orlikowski D; Parenti G; Pijnappel WWMP; Roberts M; Scherer T; Toscano A; Vissing J; van den Hout JMP; van Doorn PA; Wenninger S; van der Ploeg AT
    Eur J Neurol; 2024 Jun; ():e16383. PubMed ID: 38873957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of COVID-19 infection, the pandemic and its associated control measures on patients with Pompe disease.
    Theunissen MTM; van den Elsen RM; House TL; Crittenden B; van Doorn PA; van der Ploeg AT; Kruijshaar ME; van der Beek NAME
    J Neurol; 2024 Jan; 271(1):32-45. PubMed ID: 37982853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Inborn errors of carbohydrate metabolism.
    Martínez-Duncker I; Doederlein-Schwartz IV; Abreu-González M; García-Ortiz JE
    Front Genet; 2024; 15():1430414. PubMed ID: 38966009
    [No Abstract]   [Full Text] [Related]  

  • 16. The Timely Needs for Infantile Onset Pompe Disease Newborn Screening-Practice in Taiwan.
    Chiang SC; Chien YH; Chang KL; Lee NC; Hwu WL
    Int J Neonatal Screen; 2020 Jun; 6(2):30. PubMed ID: 33073026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The First Year Experience of Newborn Screening for Pompe Disease in California.
    Tang H; Feuchtbaum L; Sciortino S; Matteson J; Mathur D; Bishop T; Olney RS
    Int J Neonatal Screen; 2020 Mar; 6(1):9. PubMed ID: 33073007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants.
    Burton BK; Charrow J; Hoganson GE; Fleischer J; Grange DK; Braddock SR; Hitchins L; Hickey R; Christensen KM; Groepper D; Shryock H; Smith P; Shao R; Basheeruddin K
    Int J Neonatal Screen; 2020 Mar; 6(1):4. PubMed ID: 33073003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition and 6 minute walking ability in late-onset pompe disease patients after 9 years of enzyme replacement therapy.
    Terzis G; Papadimas G; Krase A; Kontou E; Arnaoutis I; Papadopoulos C
    Int J Neurosci; 2022 Jul; 132(7):699-705. PubMed ID: 33045893
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.